In humans, mTOR inhibition has been found to ameliorate some adverse consequences of aging (Blagosklonny, 2018; Lamming and Salmon, 2020), including low-grade chronic generalized inflammation nicknamed inflammaging, which has been implicated in COVID-19 pathogenesis (Fuellen et al., 2020). The gene discussed is MTOR; the disease is COVID-19.